主页 实验库实验详情
E-MTAB-7884 Cell line - High-throughput sequencin... Homo sapiens, Homo sapiens

Investigating NAFLD from RNA-seq data (human cell line Huh7) for samples under three treatments: low fat low sugar, low fat high sugar and high fat high sugar. Wild type samples are compared against DGAT2 knocked out.

·发布 2020年8月21日
24
样本数
24
实验数
1
相关文献
实验描述

Non-alcoholic fatty liver disease (NAFLD) is a major public health burden and it covers a spectrum of diseases. NAFLD starts with the accumulation of lipid droplets (LDs) within hepatocytes (steatosis). Part of the challenge of studying the mechanistic processes involved in LD accumulation and their implications on the pathogenesis of human NAFLD is due to the available models. Investigating hepatic LDs in humans is challenging and relies on liver biopsies, meaning only cross-sectional data be obtained. On the other hand, LD patterns in in vitro models are poorly defined and rarely reported. Diacylgylcerol acyltransferase (DGAT)2 is one of two enzymes that carry out the final committed step in triacylglycerol (TAG) synthesis. It is unclear whether the enzymes are able to compensate for each other or whether they have distinct roles. It has been hypothesised that DGAT1 primarily utilises exogenous fatty acids and DGAT2 uses de novo-derived fatty acids. Given the important role of this enzyme in TAG synthesis and accumulation, the aims of this study are first to create a cellular model of intrahepatocellular TAG accumulation by manipulating nutritional substrates and to investigate intracellular metabolism in wildtype and DGAT2 knockout cells under these conditions. The experimental workflow for this study is as follows: Huh7 cells (either wild type or knockout) were grown in media containing 11 mM glucose and 2% human serum (HS) for seven days before additional sugars and fatty acids (FAs) were added for a further seven days. All treatments contained 11 mM glucose and 2% HS, either with 200 µM FAs (low fat low sugar; LFLS), 5.5 mM fructose + 200 µM FAs (low fat high sugar; LFHS) or 5.5 mM fructose + 800 µM FAs (high fat high sugar; HFHS). FA metabolism, lipid droplet characteristics and transcriptomic signatures were investigated.

参考文献
Insights from the development of a human cellular model of hepatic lipid droplet accumulation and pattern for the investigation of NAFLD
Pippa J. Gunn, Camilla Pramfalk, Val Millar, Perla Troncoso-Rey, Richard F. Mithen, Maria H. Traka, Charlotte J. Green, Leanne Hodson
样本属性
Organism
Homo sapiens
Developmental stage
adult
Organism part
liver
Cell type
hepatocyte
Cell line
HuH-7
Genotype
wild type genotype, DGAT2 homozygous knockout
Disease
hepatic steatosis, hepatocellular carcinoma
实验信息
登记号
E-MTAB-7884
实验类型
Cell line - High-throughput sequencing, RNA-seq of coding RNA
物种
Homo sapiens, Homo sapiens
发布日期
2020年8月21日
提交者
Perla Troncoso Rey、 Maria Traka、 Leanne Hodson、 Pippa Gunn
分析服务
分析服务

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: [email protected]